Skip to content

Clinical trials

Phase 3 Bone Diseases, Metabolic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Diseases, Metabolic Phase: Phase 3 Country / region: United States Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20025
20034
20045
20061
20082
20092
20111
20123
20151
20171
20182
20191
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Recruiting1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Radius Health, Inc.5
Massachusetts General Hospital4
Amgen3
M.D. Anderson Cancer Center3
Genelabs Technologies2
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)2
University of Nebraska2
Columbia University1
GTx1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Diseases, Metabolic34
Osteoporosis23
Fractures, Bone8
Osteoporosis, Postmenopausal8
Amenorrhea2
Anorexia Nervosa2
Bone Diseases2
Feeding and Eating Disorders2
Lupus Erythematosus, Systemic2
Lymphoma2

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.